- Corporate Officers - B
- Buchen David A
Insider Trading History of Buchen David A
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Buchen David A since 2011.
The trader's CIK number is 1241751.
At the time of the last reporting, Buchen David A was the Sr. VP, General Counsel & Sec. of Amneal Pharmaceuticals, Inc.. (stock ticker symbol AMRX).
Also see all insider trading activities at Amneal Pharmaceuticals, Inc..
Note that in the past
BUCHEN DAVID A also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Allergan Plc (ACT) by Buchen David A
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | ACT | 0 | $0 | 30,000 | $4,779,000 | 0 | $0 |
Yearly summary of insider trading at Watson Pharmaceuticals Inc (ACT) by Buchen David A
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | ACT | 0 | $0 | 35,000 | $4,329,114 | 35,000 | $1,059,490 |
2012 | ACT | 0 | $0 | 24,294 | $1,981,418 | 40,000 | $1,131,750 |
2011 | ACT | 0 | $0 | 29,500 | $1,880,499 | 29,500 | $1,118,485 |
Yearly summary of insider trading at Amneal Pharmaceuticals, Inc. (AMRX) by Buchen David A
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | AMRX | 0 | $0 | 0 | $0 | 27,614 | $0 |
Insider trading activities at 3 companies by Buchen David A:
1. Allergan Plc (ACT)
2. Watson Pharmaceuticals Inc (ACT)
3. Amneal Pharmaceuticals, Inc. (AMRX)
Table 1. Insider trading of Allergan Plc (ACT) by Buchen David A
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-11-11 | ACT | Sale | 30,000 | 159.30 | 4,779,000 |
Table 2. Insider trading of Watson Pharmaceuticals Inc (ACT) by Buchen David A
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-08-29 | ACT | Option Ex | 10,000 | 30.38 | 303,750 |
2013-08-29 | ACT | Sale | 10,000 | 135.56 | 1,355,580 |
2013-08-09 | ACT | Option Ex | 200 | 26.14 | 5,228 |
2013-08-12 | ACT | Option Ex | 16,800 | 26.14 | 439,152 |
2013-08-09 | ACT | Sale | 200 | 135.00 | 27,000 |
2013-08-12 | ACT | Sale | 16,800 | 133.01 | 2,234,534 |
2013-03-12 | ACT | Option Ex | 8,000 | 38.92 | 311,360 |
2013-03-12 | ACT | Sale | 8,000 | 89.00 | 712,000 |
2012-08-24 | WPI | Option Ex | 25,000 | 29.43 | 735,750 |
2012-08-24 | WPI | Sale | 24,294 | 81.56 | 1,981,418 |
2012-05-25 | WPI | Option Ex | 15,000 | 26.40 | 396,000 |
2011-08-26 | WPI | Option Ex | 17,500 | 28.15 | 492,625 |
2011-08-26 | WPI | Sale | 17,500 | 65.50 | 1,146,250 |
2011-05-27 | WPI | Option Ex | 7,000 | 54.48 | 381,360 |
2011-05-27 | WPI | Sale | 7,000 | 64.10 | 448,699 |
2011-03-03 | WPI | Option Ex | 5,000 | 48.90 | 244,500 |
2011-03-03 | WPI | Sale | 5,000 | 57.11 | 285,550 |
Table 3. Insider trading of Amneal Pharmaceuticals, Inc. (AMRX) by Buchen David A
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-01-03 | AMRX | Option Ex | 27,614 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Buchen David A
(Sr. VP, General Counsel & Sec. of Amneal Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.